Cetuximab for colorectal cancer.
Yang
Feng
F
Fu
Deliang
D
Ni
Quanxing
Q
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy*; D066246:ErbB Receptors / Q000276:immunology*; D006801:Humans; D009362:Neoplasm Metastasis; D016019:Survival Analysis; D013923:Thromboembolism / Q000139:chemically induced
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab